Novel targeted drug palbociclib slows progression of hormone receptor-positive breast cancer

Anastrazole offers higher breast cancer-free survival rates than tamoxifen following DCIS

Eribulin extends overall survival for patients with advanced liposarcoma and leiomyosarcoma

Extensive lymph node surgery may not be necessary for some patients with melanoma

First effective adjuvant chemotherapy for high-risk, localised prostate cancer

New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia

Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial

ecancermedicalscience editor's choice for May 2015

Prostate cancer and pharmacokinetics: Expert discussion

Developing technical improvements to bladder radiotherapy using online imaging

Advances in prostate cancer focal radiation treatments

Targeted Intraoperative radiotherapy plus lumpectomy non-inferior to EBRT in preventing breast cancer recurrence